Summit Therapeutics (SMMT) Earnings Date & Reports
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases... Show more
SMMT is expected to report earnings to rise 69.54% to -22 cents per share on March 12
Q4'25
Est.
$-0.22
Q3'25
Beat
by $0.04
Q2'25
Missed
by $0.03
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.01
The last earnings report on October 20 showed earnings per share of -12 cents, beating the estimate of -17 cents. With 750.69K shares outstanding, the current market capitalization sits at 14.01B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SMMT showed earnings on October 20, 2025. You can read more about the earnings report here.